{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T07:57:41Z","timestamp":1790668661897,"version":"4.1.0"},"reference-count":30,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["obgyn.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pregnancy"],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Seizure disorders are a common comorbidity of pregnancy, leading to increased maternal and neonatal complications. In particular, we sought to identify the impact of seizure disorders on severe maternal morbidity (SMM) and hypertensive disorders of pregnancy in a contemporary cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Retrospective cohort study using the National Inpatient Sample (NIS) database from 2017 to 2021 through Healthcare Cost and Utilization Project (HCUP)\/Agency for Healthcare and Research Quality (AHRQ), utilizing delivery admissions. Pregnant patients with seizure disorder were identified by International Classification of Diseases (ICD)\u201010 codes. We assessed the prevalence of seizure disorders in pregnancy and compared baseline characteristics of those with a seizure disorder to those without a seizure disorder using weighted sampling per the NIS guidelines. Our primary outcome was a composite of SMM as defined by the Centers for Disease Control. Secondary outcomes were hypertensive disorders of pregnancy, hemorrhage, cesarean delivery, maternal death, and maternal length of stay. Statistical analyses were performed with survey weights and included Student's\n                      <jats:italic>t<\/jats:italic>\n                      \u2010test,\n                      <jats:italic>\u03c7<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      analysis, and linear and logistic regression to control for confounders. A sensitivity analysis was performed among only subjects with HDP to assess adverse outcomes in this population.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Over a 5\u2010year period, more than 16 million subjects were included, of which a total of 83,050 (0.5%) pregnant patients had an ICD\u201010 diagnosis for seizure disorder at the time of delivery. The prevalence increased from 2017 to 2021 (0.45% to 0.54%,\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0&lt;\u00a00.001). Patients with an ICD\u201010 code for seizure disorder were more likely to use tobacco and have ICD\u201010 or CMR code for obesity, diabetes mellitus, and hypertension. Those with a seizure disorder were more likely to experience the composite SMM, hemolysis, elevated liver enzymes, low platelets (HELLP) syndrome, eclampsia, hemorrhage, cesarean delivery, maternal death, and longer length of stay than those without a seizure disorder during their delivery hospitalization. In the adjusted analyses, seizure disorder was associated with SMM (adjusted odds ratio [aOR], 2.16; 95% confidence interval [CI], 2.03\u20132.30) and maternal death (aOR, 6.30; 95% CI, 3.07\u201312.942). Having a seizure disorder was also associated with hemorrhage, cesarean, severe forms of hypertensive disorders of pregnancy, and increased length of stay. SMM remained elevated in the seizure disorder population in the sensitivity analysis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Seizure disorder in pregnancy increased in prevalence from 2017 to 2021 and is associated with risk factors such as obesity, tobacco use, diabetes mellitus, and hypertension. These patients are more likely to experience SMM, death, and severe forms of hypertensive disorders of pregnancy than pregnant patients without a seizure disorder.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/pmf2.70466","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T07:36:31Z","timestamp":1790667391000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Severe maternal morbidity in pregnancies complicated by maternal seizure disorder"],"prefix":"10.1002","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-5682-5857","authenticated-orcid":false,"given":"Janki","family":"Amin","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology Advocate Aurora Health  Chicago Illinois USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1195-6596","authenticated-orcid":false,"given":"Brianna","family":"Lau","sequence":"additional","affiliation":[{"name":"Chicago Medical School Rosalind Franklin University of Medicine and Science  Chicago Illinois USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8234-1815","authenticated-orcid":false,"given":"Brandie D.","family":"Taylor","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology University of Texas Medical Branch  Galveston Texas USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Calla","family":"Holmgren","sequence":"additional","affiliation":[{"name":"Department of Maternal Fetal Medicine Advocate Aurora Health  Chicago Illinois USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6189-2354","authenticated-orcid":false,"given":"Rachel K.","family":"Harrison","sequence":"additional","affiliation":[{"name":"Department of Maternal Fetal Medicine Advocate Aurora Health  Chicago Illinois USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,9,29]]},"reference":[{"issue":"5","key":"e_1_2_11_2_1","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1600-0404.1987.tb05459.x","article-title":"Incidence of Seizures During Pregnancy, Labor and Puerperium in Epileptic Women: A Prospective Study","volume":"75","author":"Bardy A. H.","year":"1987","journal-title":"Acta Neurologica Scandinavica"},{"issue":"11","key":"e_1_2_11_3_1","doi-asserted-by":"crossref","first-page":"e1031","DOI":"10.1212\/WNL.0000000000006173","article-title":"Unintended Pregnancy, Prenatal Care, Newborn Outcomes, and Breastfeeding in Women With Epilepsy","volume":"91","author":"Johnson E. L.","year":"2018","journal-title":"Neurology"},{"issue":"1","key":"e_1_2_11_4_1","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1212\/CON.0000000000001056","article-title":"Epilepsy and Pregnancy","volume":"28","author":"Li Y.","year":"2022","journal-title":"Continuum"},{"issue":"5","key":"e_1_2_11_5_1","doi-asserted-by":"crossref","first-page":"e213","DOI":"10.1097\/AOG.0000000000003827","article-title":"Gynecologic Management of Adolescents and Young Women With Seizure Disorders. ACOG Committee Opinion No. 806","volume":"135","author":"American College of Obstetricians and Gynecologists","year":"2020","journal-title":"Obstetrics and Gynecology"},{"key":"e_1_2_11_6_1","unstructured":"2024.\u201cNew Guidelines for Seizure Disorder and Pregnancy: AAN AES and SMFM Collaboration.\u201d TouchNeurology. Published December 20 2024. Accessed March 25 2026.https:\/\/pubmed.ncbi.nlm.nih.gov\/26147878\/."},{"issue":"2","key":"e_1_2_11_7_1","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1212\/WNL.0b013e3181a6b2f8","article-title":"Practice Parameter Update: Management Issues for Women With Epilepsy\u2014Focus on Pregnancy (An Evidence\u2010Based Review): Obstetrical Complications and Change in Seizure Frequency: Report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society","volume":"73","author":"Harden C. L.","year":"2009","journal-title":"Neurology"},{"issue":"9","key":"e_1_2_11_8_1","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1001\/jamaneurol.2015.1017","article-title":"Mortality and Morbidity During Delivery Hospitalization Among Pregnant Women With Epilepsy in the United States","volume":"72","author":"MacDonald S. C.","year":"2015","journal-title":"JAMA Neurology"},{"key":"e_1_2_11_9_1","volume-title":"Identifying Severe Maternal Morbidity (SMM)","author":"Centers for Disease Control and Prevention","year":"2024"},{"issue":"25","key":"e_1_2_11_10_1","doi-asserted-by":"crossref","first-page":"7917","DOI":"10.1080\/14767058.2021.1938528","article-title":"Maternal Morbidity and Mortality Associated With Epilepsy","volume":"35","author":"Gyamfi\u2010Bannerman C.","year":"2022","journal-title":"The Journal of Maternal\u2010Fetal & Neonatal Medicine"},{"issue":"11","key":"e_1_2_11_11_1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0225334","article-title":"Maternal Complications in Pregnancy and Childbirth for Women With Epilepsy: Time Trends in a Nationwide Cohort","volume":"14","author":"Danielsson K. C.","year":"2019","journal-title":"PLoS ONE"},{"issue":"9","key":"e_1_2_11_12_1","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1001\/jamaneurol.2024.2375","article-title":"Risk of Perinatal and Maternal Morbidity and Mortality Among Pregnant Women With Epilepsy","volume":"81","author":"Razaz N.","year":"2024","journal-title":"JAMA Neurology"},{"key":"e_1_2_11_13_1","volume-title":"Healthcare Cost and Utilization Project (HCUP)","author":"HCUP National Inpatient Sample (NIS)","year":"2012"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.1097\/EDE.0b013e3181a819a1"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10654\u2010019\u201000494\u20106"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1370\/afm.2792"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.5888\/pcd21.240313"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.7326\/M17\u20101485"},{"issue":"5","key":"e_1_2_11_19_1","doi-asserted-by":"crossref","first-page":"e85","DOI":"10.1111\/j.1528-1167.2012.03439.x","article-title":"Predictors of Seizures During Pregnancy in Women With Epilepsy","volume":"53","author":"Thomas S. V.","year":"2012","journal-title":"Epilepsia"},{"issue":"1","key":"e_1_2_11_20_1","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1528-1167.2007.01412.x","article-title":"Seizure Control in Antiepileptic Drug\u2010Treated Pregnancy","volume":"49","author":"Vajda F. J.","year":"2008","journal-title":"Epilepsia"},{"issue":"2","key":"e_1_2_11_21_1","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.seizure.2013.10.003","article-title":"Impact of Planning of Pregnancy in Women With Epilepsy on Seizure Control During Pregnancy and on Maternal and Neonatal Outcomes","volume":"23","author":"Abe K.","year":"2014","journal-title":"Seizure"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2017.1310"},{"issue":"6","key":"e_1_2_11_23_1","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1684\/epd.2019.1105","article-title":"Management of Epilepsy in Pregnancy: A Report From the International League Against Epilepsy Task Force on Women and Pregnancy","volume":"21","author":"Tomson T.","year":"2019","journal-title":"Epileptic Disorders"},{"issue":"10","key":"e_1_2_11_24_1","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1586\/14737175.2015.1083422","article-title":"Management of Epilepsy During Pregnancy","volume":"15","author":"Voinescu P. E.","year":"2015","journal-title":"Expert Review of Neurotherapeutics"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2021.5487"},{"issue":"2","key":"e_1_2_11_26_1","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/GCO.0b013e32834feb6a","article-title":"Pregnancy Complications in Patients With Epilepsy","volume":"24","author":"Borthen I.","year":"2012","journal-title":"Current Opinion in Obstetrics and Gynecology"},{"issue":"3","key":"e_1_2_11_27_1","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1212\/01.CON.0000431383.14061.e6","article-title":"Pregnancy, Epilepsy, and Women's Issues","volume":"19","author":"Pennell P. B.","year":"2013","journal-title":"Continuum"},{"issue":"5","key":"e_1_2_11_28_1","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1161\/HYPERTENSIONAHA.120.14781","article-title":"Subtypes of Preeclampsia: Recognition and Determining Clinical Usefulness","volume":"77","author":"Roberts J. M.","year":"2021","journal-title":"Hypertension"},{"issue":"7","key":"e_1_2_11_29_1","doi-asserted-by":"crossref","first-page":"e72","DOI":"10.1111\/epi.12621","article-title":"SUDEP and Epilepsy\u2010Related Mortality in Pregnancy","volume":"55","author":"Edey S.","year":"2014","journal-title":"Epilepsia"},{"issue":"1","key":"e_1_2_11_30_1","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ijmedinf.2006.11.005","article-title":"Reliability of Diagnoses Coding With ICD\u201010","volume":"77","author":"Stausberg J.","year":"2008","journal-title":"International Journal of Medical Informatics"},{"key":"e_1_2_11_31_1","doi-asserted-by":"crossref","DOI":"10.1201\/9781003099062","volume-title":"Maternal\u2010fetal evidence based guidelines","author":"Berghella V","year":"2022"}],"container-title":["Pregnancy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pmf2.70466","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/pmf2.70466","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pmf2.70466","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T07:36:35Z","timestamp":1790667395000},"score":1,"resource":{"primary":{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/10.1002\/pmf2.70466"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,29]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["10.1002\/pmf2.70466"],"URL":"https:\/\/doi.org\/10.1002\/pmf2.70466","archive":["Portico"],"relation":{},"ISSN":["2997-9684","2997-9684"],"issn-type":[{"value":"2997-9684","type":"print"},{"value":"2997-9684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,29]]},"assertion":[{"value":"2026-04-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-29","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70466"}}